NCT00947063View on ClinicalTrials.gov

To Demonstrate the Relative Bioavailability Study of Promethazine HCl 50 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

August 31, 2004

Study Completion Date

August 31, 2004

Conditions
Allergy
Interventions
DRUG

Promethazine HCl 50 mg Tablets (Sandoz, Inc)

DRUG

Phenergan (Promethazine HCl) 50 mg Tablets (Wyeth Laboratories)

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY